174 related articles for article (PubMed ID: 9362376)
1. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator.
Barrett-Bergshoeff M; Noorman F; Bos R; Rijken DC
Thromb Haemost; 1997 Apr; 77(4):718-24. PubMed ID: 9134649
[TBL] [Abstract][Full Text] [Related]
3. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
Smedsrød B; Einarsson M
Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.
Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035
[TBL] [Abstract][Full Text] [Related]
5. Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator.
Biessen EA; van Teijlingen M; Vietsch H; Barrett-Bergshoeff MM; Bijsterbosch MK; Rijken DC; van Berkel TJ; Kuiper J
Circulation; 1997 Jan; 95(1):46-52. PubMed ID: 8994415
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA) by dextran: a new explanation for its antithrombotic effect.
Noorman F; Barrett-Bergshoeff MM; Bekkers M; Emeis JJ; Rijken DC
Thromb Haemost; 1997 Oct; 78(4):1249-54. PubMed ID: 9364993
[TBL] [Abstract][Full Text] [Related]
7. Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.
Seydel W; Stang E; Roos N; Krause J
Arzneimittelforschung; 1991 Feb; 41(2):182-6. PubMed ID: 1904231
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.
Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ
Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113
[TBL] [Abstract][Full Text] [Related]
9. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
[TBL] [Abstract][Full Text] [Related]
10. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
Camani C; Gavin O; Kruithof EK
Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
[TBL] [Abstract][Full Text] [Related]
11. Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration.
Biessen EA; Noorman F; van Teijlingen ME; Kuiper J; Barrett-Bergshoeff M; Bijsterbosch MK; Rijken DC; van Berkel TJ
J Biol Chem; 1996 Nov; 271(45):28024-30. PubMed ID: 8910412
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator is endocytosed by mannose and galactose receptors of rat liver cells.
Smedsrød B; Einarsson M; Pertoft H
Thromb Haemost; 1988 Jun; 59(3):480-4. PubMed ID: 2847350
[TBL] [Abstract][Full Text] [Related]
13. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
[TBL] [Abstract][Full Text] [Related]
14. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
Narita M; Bu G; Herz J; Schwartz AL
J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
[TBL] [Abstract][Full Text] [Related]
15. Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2.
Otter M; Van Berkel TJ; Rijken DC
Thromb Haemost; 1989 Sep; 62(2):667-72. PubMed ID: 2510347
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
17. Hepatic sinusoidal endothelium heterogeneity with respect to mannose receptor activity is interleukin-1 dependent.
Asumendi A; Alvarez A; Martinez I; Smedsrød B; Vidal-Vanaclocha F
Hepatology; 1996 Jun; 23(6):1521-9. PubMed ID: 8675173
[TBL] [Abstract][Full Text] [Related]
18. Internalization of recombinant tissue-type plasminogen activator by isolated rat hepatocytes is via coated pits.
Marks GJ; Hart TK; Rush GF; Hoffstein ST; Fong KL; Bugelski PJ
Thromb Haemost; 1990 Apr; 63(2):251-8. PubMed ID: 1973006
[TBL] [Abstract][Full Text] [Related]
19. Degradation of tissue-type plasminogen activator by human monocyte-derived macrophages is mediated by the mannose receptor and by the low-density lipoprotein receptor-related protein.
Noorman F; Braat EA; Rijken DC
Blood; 1995 Nov; 86(9):3421-7. PubMed ID: 7579446
[TBL] [Abstract][Full Text] [Related]
20. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells.
Higuchi Y; Nishikawa M; Kawakami S; Yamashita F; Hashida M
Int J Pharm; 2004 Dec; 287(1-2):147-54. PubMed ID: 15541921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]